Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactobacillus acidophilus lysates are a type of postbiotic, which are preparations of inanimate microorganisms and/or their components that can confer health benefits. These lysates are produced by breaking open the cells of Lactobacillus acidophilus, a probiotic bacterium naturally found in the human body. [10, 14] The resulting substance contains various cellular components like peptidoglycans, proteins, and DNA, which have been shown to have immunomodulatory effects. [14] In preclinical studies, L. acidophilus lysates have demonstrated the ability to enhance anti-tumor immunity, particularly when combined with checkpoint inhibitors like anti-CTLA-4 antibodies in colorectal cancer models. [2, 5] The mechanism involves modulating the tumor microenvironment by increasing the presence of beneficial immune cells such as CD8+ T cells and effector memory T cells, while decreasing immunosuppressive cells like regulatory T cells (Tregs) and M2-type macrophages. [5] Beyond oncology, these lysates are also explored for their antimicrobial properties and are used as ingredients in supplements and cosmetic products. [1, 23]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lactobacillus acidophilus lysates.